Nektar Therapeutics
NKTR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$118,961 | -$276,056 | -$368,198 | -$523,837 |
| Dep. & Amort. | $4,391 | $7,815 | $13,030 | $14,146 |
| Deferred Tax | $0 | -$140 | $2,708 | $8,023 |
| Stock-Based Comp. | $21,612 | $33,388 | $57,320 | $94,674 |
| Change in WC | -$6,239 | -$19,800 | $492 | -$23,076 |
| Other Non-Cash | -$76,512 | $62,187 | -$9,359 | $17,410 |
| Operating Cash Flow | -$175,709 | -$192,606 | -$304,007 | -$412,660 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,468 | -$865 | -$5,676 | -$14,989 |
| Net Acquisitions | $65,386 | $0 | $13,196 | -$217,766 |
| Inv. Purchases | -$261,709 | -$511,699 | -$467,914 | -$960,689 |
| Inv. Sales/Matur. | $340,361 | $650,883 | $826,229 | $1,178,455 |
| Other Inv. Act. | $0 | $1,245 | $0 | $217,766 |
| Investing Cash Flow | $142,570 | $139,564 | $365,835 | $202,777 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $30 | $758 | $33,238 |
| Stock Repurch. | -$3,000 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $45,118 | $0 | $750 | $3,000 |
| Financing Cash Flow | $42,118 | $30 | $1,508 | $36,238 |
| Forex Effect | -$4 | $62 | -$327 | -$92 |
| Net Chg. in Cash | $8,975 | -$52,950 | $63,009 | -$173,737 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35,277 | $88,227 | $25,218 | $198,955 |
| End Cash | $44,252 | $35,277 | $88,227 | $25,218 |
| Free Cash Flow | -$177,177 | -$193,471 | -$309,683 | -$427,649 |